Characterization of glycosylation profiles of HIV-1 transmitted/founder envelopes by mass spectrometry

Journal of Virology

Volumn 85, Issue 16, 2011, Pages 8270-8284

  Go, Eden P ^a   Hewawasam, Geetha ^a,d   Liao, Hua Xin ^b   Chen, Haiyan ^b   Ping, Li Hua ^c   Anderson, Jeffrey A ^c   Hua, David C ^a   Haynes, Barton F ^b   Desaire, Heather ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d STOWERS INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CHEMICAL COMPOSITION; CLADISTICS; DEGLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79961184231     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05053-11     Document Type: Article

References (69)

1. Abrahams, M. R., et al. 2009. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-Poisson distribution of transmitted variants. J. Virol. 83:3556-3567.
2. An, H. J., J. W. Froehlich, and C. B. Lebrilla. 2009. Determination of glycosylation sites and site-specific heterogeneity in glycoproteins. Curr. Opin. Chem. Biol. 13:421-426.
3. An, H. J., S. R. Kronewitter, M. L. de Leoz, and C. B. Lebrilla. 2009. Glycomics and disease markers. Curr. Opin. Chem. Biol. 13:601-607.
4. Andre, S., et al. 1998. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J. Virol. 72:1497-1503.
5. Binley, J. M., et al. 2010. Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization. J. Virol. 84:5637-5655.
6. Budnik, B. A., R. S. Lee, and J. A. J. Steen. 2006. Global methods for protein glycosylation analysis by mass spectrometry. Biochim. Biophys. Acta 1764: 1870-1880.
7. Chakrabarti, B. K., et al. 2002. Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization. J. Virol. 76:5357-5368.
8. Chohan, B., et al. 2005. Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels. J. Virol. 79:6528-6531.
9. Cooper, C. A., E. Gasteiger, and N. H. Packer. 2001. GlycoMod-a software tool for determining glycosylation compositions from mass spectrometric data. Proteomics 1:340-349.
10. Cutalo, J. M., L. J. Deterding, and K. B. Tomer. 2004. Characterization of glycopeptides from HIV-I(SF2) gp120 by liquid chromatography mass spectrometry. J. Am. Soc. Mass Spectrom. 15:1545-1555.
11. Dalpathado, D. S., and H. Desaire. 2008. Glycopeptide analysis by mass spectrometry. Analyst 133:731-738.
12. Dalpathado, D. S., et al. 2006. Comparative glycomics of the glycoprotein follicle stimulating hormone: glycopeptide analysis of isolates from two mammalian species. Biochemistry 45:8665-8673.
13. Derdeyn, C. A., et al. 2004. Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 303:2019-2022.
14. Desaire, H., and D. Hua. 2009. When can glycopeptides be assigned based solely on high-resolution mass spectrometry data? Int. J. Mass Spectrom. 287:21-26.
15. Doores, K. J., et al. 2010. Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens. Proc. Natl. Acad. Sci. U. S. A. 107: 13800-13805.
16. Drake, P. M., et al. 2010. Sweetening the pot: adding glycosylation to the biomarker discovery equation. Clin. Chem. 56:223-236.
17. Geyer, H., C. Holschbach, G. Hunsmann, and J. Schneider. 1988. Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120. J. Biol. Chem. 263:11760-11767.
18. Geyer, H., and R. Geyer. 2006. Strategies for analysis of glycoprotein glycosylation. Biochim. Biophys. Acta 1764:1853-1869.
19. Go, E. P., et al. 2009. Glycosylation site-specific analysis of clade C HIV-1 envelope proteins. J. Proteome Res. 8:4231-4242.
20. Go, E. P., et al. 2008. Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility. J. Proteome Res. 7:1660-1674.
21. Go, E. P., et al. 2007. GlycoPep DB: a tool for glycopeptide analysis using a "Smart Search." Anal. Chem. 79:1708-1713.
22. Go, E. P., et al. Methods development for analysis of partially deglycosylated proteins and application to an HIV envelope protein vaccine candidate. Int. J. Mass Spectrom., in press.
23. Hagglund, P., J. Bunkenborg, F. Elortza, O. N. Jensen, and P. Roepstorff. 2004. A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation. J. Proteome Res. 3:556-566.
24. Hagglund, P., et al. 2007. An enzymatic deglycosylation scheme enabling identification of core fucosylated N-glycans and O-glycosylation site mapping of human plasma proteins. J. Proteome Res. 6:3021-3031.
25. Han, J. C., and G. Y. Han. 1994. A procedure for quantitative determination of Tris(2-carboxyethyl)phosphine, an odorless reducing agent more stable and effective than dithiothreitol. Anal. Biochem. 220:5-10.
26. Hirabayashi, J. 2004. Lectin-based structural glycomics: glycoproteomics and glycan profiling. Glycoconj. J. 21:35-40.
27. Ihaka, R., and R. Gentleman. 1996. R: a language for data analysis and graphics. J. Comput. Graph. Stat. 5:299-314.
28. Irungu, J., E. P. Go, D. S. Dalpathado, and H. Desaire. 2007. Simplification of mass spectral analysis of acidic glycopeptides using GlycoPep ID. Anal. Chem. 79:3065-3074.
29. Irungu, J., et al. 2008. Comparison of HPLC/ESI-FTICR MS versus MALDI-TOF/TOF MS for glycopeptide analysis of a highly glycosylated HIV envelope glycoprotein. J. Am. Soc. Mass Spectrom. 19:1209-1220.
30. Jones, J., S. S. Krag, and M. J. Betenbaugh. 2005. Controlling N-linked glycan site occupancy. Biochim. Biophys. Acta 1726:121-137.
31. Jung, K. Y., W. R. Cho, and F. E. Regnier. 2009. Glycoproteomics of plasma based on narrow selectivity lectin affinity chromatography. J. Proteome Res. 8:643-650.
32. Keele, B. F., and C. A. Derdeyn. 2009. Genetic and antigenic features of the transmitted virus. Curr. Opin. HIV AIDS 4:352-357.
33. Keele, B. F., et al. 2008. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. U. S. A. 105:7552-7557.
34. Kong, L., et al. 2010. Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity. J. Mol. Biol. 403: 131-147.
35. Kornfeld, R., and S. Kornfeld. 1985. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54:631-664.
36. Kraft, Z., et al. 2008. Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted viruses. J. Virol. 82:5912-5921.
37. Larkin, M. A., et al. 2007. Clustal W and Clustal X version 2.0. Bioinformatics 23:2947-2948.
38. Learn, G. H., et al. 2002. Virus population homogenization following acute human immunodeficiency virus type 1 infection. J. Virol. 76:11953-11959.
39. Leonard, C. K., et al. 1990. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265:10373-10382.
40. Li, M., et al. 2006. Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in southern Africa. J. Virol. 80:11776-11790.
41. Liao, H. X., et al. 2006. A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses. Virology 353:268-282.
42. Liu, Y., et al. 2008. Env length and N-linked glycosylation following transmission of human immunodeficiency virus type 1 subtype B viruses. Virology 374:229-233.
43. Maley, F., R. B. Trimble, A. L. Tarentino, and T. H. Plummer, Jr. 1989. Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases. Anal. Biochem. 180:195-204.
44. Medzihradszky, K. F. 2005. Characterization of protein N-glycosylation. Methods Enzymol. 405:116-138.
45. Mizuochi, T., et al. 1990. Diversity of oligosaccharide structures on the envelope glycoprotein gp 120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues. J. Biol. Chem. 265:8519-8524.
46. Mizuochi, T., et al. 1988. Carbohydrate structures of the human-immunodeficiency-virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese-hamster ovary cells. Biochem. J. 254:599-603.
47. Morelle, W., K. Canis, F. Chirat, V. Faid, and J. C. Michalski. 2006. The use of mass spectrometry for the proteomic analysis of glycosylation. Proteomics 6:3993-4015.
48. Morelle, W., and J. C. Michalski. 2007. Analysis of protein glycosylation by mass spectrometry. Nat. Protoc. 2:1585-1602.
49. Nawaz, F., et al. 2011. The genotype of early-transmitting HIV gp120s promotes alphabeta-reactivity, revealing alphabetaCD4+ T cells as key targets in mucosal transmission. PLoS Pathog. 7:e1001301.
50. Nicoli, R., et al. 2010. Advances in LC platforms for drug discovery. Expert Opin. Drug Discov. 5:475-489.
51. North, S. J., P. G. Hitchen, S. M. Haslam, and A. Dell. 2009. Mass spectrometry in the analysis of N-linked and O-linked glycans. Curr. Opin. Struct. Biol. 19:498-506.
52. Paulson, J. C., and K. J. Colley. 1989. Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. J. Biol. Chem. 264: 17615-17618.
53. Paulson, J. C. 1989. Glycoproteins: what are the sugar chains for? Trends Biochem.Sci. 14:272-276.
54. Qiu, R. Q., and F. E. Regnier. 2005. Use of multidimensional lectin affinity chromatography in differential glycoproteomics. Anal. Chem. 77:2802-2809.
55. Rademeyer, C., et al. 2007. Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies. Virology 368:172-181.
56. Raska, M., et al. 2010. Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition. J. Biol. Chem. 285:20860-20869.
57. Rerks-Ngarm, S., et al. 2009. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361:2209-2220.
58. Salazar-Gonzalez, J. F., et al. 2009. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection J. Exp. Med. 206:1273-1289.
59. Schulz, B. L., and M. Aebi. 2009. Analysis of glycosylation site occupancy reveals a role for Ost3p and Ost6p in site-specific N-glycosylation efficiency. Mol. Cell. Proteomics 8:357-364.
60. Segu, Z. M., A. Hussein, M. V. Novotny, and Y. Mechref. 2010. Assigning N-glycosylation sites of glycoproteins using LC/MSMS in conjunction with Endo-M/exoglycosidase mixture. J. Proteome Res. 9:3598-3607.
61. Tarentino, A. L., and T. H. Plummer, Jr. 1994. Enzymatic deglycosylation of asparagine-linked glycans: purification, properties, and specificity of oligosaccharide-cleaving enzymes from Flavobacterium meningosepticum. Methods Enzymol. 230:44-57.
62. Ungar, D. 2009. Golgi linked protein glycosylation and associated diseases. Semin. Cell Dev. Biol. 20:762-769.
63. Wyss, D. F., et al. 1995. Conformation and function of the N-linked glycan in the adhesion domain of human CD2. Science 269:1273-1278.
64. Yamaguchi, H. 2002. Chaperone-like functions of N-glycans in the formation and stabilization of protein conformation. Trends Glycosci. Glycotechnol. 14:139-151.
65. Yeh, J. C., J. R. Seals, C. I. Murphy, H. van Halbeek, and R. D. Cummings. 1993. Site-specific N-glycosylation and oligosaccharide structures of recombinant HIV-1 gp120 derived from a baculovirus expression system. Biochemistry 32:11087-11099.
66. Zaia, J. 2008. Mass spectrometry and the emerging field of glycomics. Chem. Biol. 15:881-892.
67. Zhang, M., et al. 2004. Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 14:1229-1246.
68. Zhang, Y., E. P. Go, and H. Desaire. 2008. Maximizing coverage of glycosylation heterogeneity in MALDI-MS analysis of glycoproteins with up to 27 glycosylation sites. Anal. Chem. 80:3144-3158.
69. Zhu, X., C. Borchers, R. J. Bienstock, and K. B. Tomer. 2000. Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells. Biochemistry 39:11194-11204.